Curcumin inhibits the cancer‑associated fibroblast‑derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway

Int J Oncol. 2022 Jul;61(1):85. doi: 10.3892/ijo.2022.5375. Epub 2022 May 27.

Abstract

The present study aimed to investigate whether the Janus‑activated kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) signaling pathway is a critical mechanism underlying the cancer‑associated fibroblast (CAF)‑induced chemoresistance of gastric cancer (GC). In addition, the present study tried to suggest a natural product to compromise the effects of CAF on the chemoresistance of GC. The results of cell proliferation assay revealed that the conditioned medium (CM) collected from CAFs further increased resistance to 5‑fluorouracil (5‑FU) in GC cell lines. Secretome analysis revealed that the levels of several secreted proteins, including C‑C motif chemokine ligand 2, C‑X‑C motif chemokine ligand 1, interleukin (IL)‑6 and IL‑8, were increased in the CM from CAFs co‑cultured with cancer cells compared to CM from cancer cells. Western blot analysis revealed that CAFs activated the JAK/STAT3 signaling pathway in cancer cells. The experimental models revealed that curcumin abrogated the CAF‑mediated activation of the JAK/STAT3 signaling pathway in GC cells. In vivo data revealed the synergistic effects of curcumin with 5‑FU treatment in xenograft GC tumors. These data strongly suggest that the suppression of the JAK/STAT3 signaling pathway counteracts the CAF‑induced chemoresistance of GC cells. It is suggested that curcumin may be a suitable natural product which may be used to overcome chemoresistance by inhibiting the CAF‑induced activation of the JAK/STAT3 signaling pathway in GC.

Keywords: cancer‑associated fibroblast; chemoresistance; curcumin; gastric cancer; tumor microenvironment.

MeSH terms

  • Biological Products* / pharmacology
  • Cancer-Associated Fibroblasts* / pathology
  • Chemokines / metabolism
  • Curcumin* / pharmacology
  • Curcumin* / therapeutic use
  • Drug Resistance, Neoplasm
  • Fluorouracil / metabolism
  • Fluorouracil / pharmacology
  • Fluorouracil / therapeutic use
  • Humans
  • Interleukin-6 / metabolism
  • Janus Kinases
  • Ligands
  • STAT3 Transcription Factor / metabolism
  • Signal Transduction
  • Stomach Neoplasms* / pathology

Substances

  • Biological Products
  • Chemokines
  • Interleukin-6
  • Ligands
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Janus Kinases
  • Curcumin
  • Fluorouracil

Grants and funding

The present study was supported by grants from the National Research Foundation of Korea (NRF) funded by the Ministry of Education (no. 2020R1A6A1A03043539 and 2020R1I1A1A01070961 and a NRF grant funded by the Korean government, the Ministry of Science and ICT (no. 2020R1A2C1006273).